| Bioactivity | RIPK1-IN-26 is a potent receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor with cell anti-necroptosis potency. RIPK1-IN-26 demonstrats good metabolic stability and good binding specificity in mice. RIPK1-IN-26 is promising for research of PET imaging probe development and neurodegenerative disorders[1]. |
| CAS | 2252271-96-6 |
| Formula | C15H20FNO2 |
| Molar Mass | 265.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Luo T, et al. Design, synthesis, and preclinical evaluation of 11C/18F-labeled inhibitors for RIPK1 PET imaging. Eur J Med Chem. 2024 Sep 6;279:116851. |
RIPK1-IN-26
CAS: 2252271-96-6 F: C15H20FNO2 W: 265.32
RIPK1-IN-26 is a potent receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor with cell anti-necropto
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.